BioCentury
ARTICLE | Clinical News

Biomira starts Phase IIb with BLP25

August 9, 2000 7:00 AM UTC

BIOM started a Canadian 166-patient Phase IIb trial of BLP25 vaccine to treat advanced non-small cell lung cancer (see BioCentury, Jan. 31). The trial will enroll patients who remained stable or show...